Tag Archives | BIO ETF’s

Biotech Bull Market Rolls On in a Volatile Q2 2015: XBI Up 12.4%

Dealmaking and Fast Money Fuel Biotechs Q2 2015 Review Despite a major down trend at the end of April and the recent sell-off, the sector outperformed in Q2 of 2015. The S&P was down 1% and flat YTD. The XBI Biotech ETF continues to be the sector ETF leader up 12.41% compared to 5% for the […]

Continue Reading 0

BIO Investor Forum Oct. 7-8, 2014: #1 How Fragile is the Biotech Rally?

Five Year Bull Market in Biotech  We attended the Bio Investor Forum in San Francisco this week and it was well attended with over 600 participants and over 120 companies presenting. Attendees included VCs , investors, industry executives, bankers, and media. The Bio Investor Forum is one of the best meetings for current issues and […]

Continue Reading 0

FED Comments Focus On “Bubble” Stocks In Social Media and Biotech…. Update-1

Update 8PM EDT NASDAQ Holds Losses to 0.54%-Futures Stable Biotech Damage Across the Sector-Rayno Life Science Portfolio Notes Large Caps off about 2% (FBT), but Gilead (GILD) down only 0.95% and Roche (RHHBY) up 0.28%. Rayno Biopharma stocks all red down 3-4% with XBI down 3.86%, IBB down 2.2%. Damage not as severe in Diagnostics […]

Continue Reading 0

Snap-Back Rally in Biotech Up 4+% Friday

Life Science Stocks Surge Ahead From February Lows  NASDAQ Up 1.67%, IBB Up 4%, FBIOX up 4.72%, XBI up 5.64%, XLV up 1.7% The soaring biotech sector would not let a losing week go by and took off early Friday erasing most losses for the week 2/3 to 2/7. Institutions can apparently drive biotech stocks […]

Continue Reading 0

Biotech Rally Update at New Highs: ETFs (IBB,PBE) Beat Five Star Fidelity Fund (FBIOX)

Up until recently the Fidelity Select Biotechnology Fund (FBIOX) has outperformed all ETFs but now the IBB and PBE are leaders over the last 3 months. There have been two recent mini-corrections but over the past two weeks the IBB has soared up almost 15% for the past 3 months.The PBE has also outperformed but the […]

Continue Reading 0

Biotechnology Bull Market Gets Second Wind To All Time Highs: ALR, GILD, ILMN,

Dow, S&P and Biotech Sector Hit All Time Highs NASDAQ Still 1000+Pts Under 2000 High Levels After a 10% sell-off in early October many large cap biopharmaceutical and diagnostic stocks are at new highs with the major indices at or near their October highs. The bellwether ETF IBB ($211.30) is flat after the index was […]

Continue Reading 0

Market Sell-Off Accelerating As Shut-Down Drags On Update 10/4 CLDX

Life Science Trading Update 10/4/13       NASDAQ up 0.88% at 3809 Is the market expecting Boehner to settle? Green screen today with most market leaders up  about 2%: AMGN, BIIB, PCYC, REGN, VPHM. ETFs up in the 1% range. DX and Tools Movers: GHDX, ILMN. Mid and small-cap biopharmaceuticals: very strong except notable weakness […]

Continue Reading 0

Stocks Snap-Back After Sell-Off: NASDAQ Up 0.55%, ASTX Soars

But Uncertainty Clouds Intermediate Term Economic Outlook:  Oil prices, Emerging Markets, Russia and the FED Concerns about another Middle East war and a spike in oil prices waned a bit today but many “undertoads” remain such as weak economic data, taper talk, Q4 earnings and a slowdown in housing. So yesterday’s grim warnings about a […]

Continue Reading 0

Risk Off Resumes With Profit Taking-Biotechs Off 5% From Highs

Biotech Sector Momentum Quits-IBB at Support Level of $189 NASDAQ Off 1.73% to 3605 Have fund managers raised cash and gone on vacation? Moreover many weaker sectors have  become leaders like gold, silver,materials and energy. Walmart and Cisco are leading the way down against a back drop of stronger economic data.Over the past five days […]

Continue Reading 0

Bernanke Bounce Carries Biotechs To New Highs

Strong NASDAQ Up 1.35%-IBB Hits 188.82 All Time High A stealth rally that began with futures after the close yesterday was triggered by Bernanke comments interpreted by the market as backtracking on “tapering”. Maybe Bernanke was trying to soften his perceived  tapering (not tightening) position to help the trashed bond market (LQD) down about 6% […]

Continue Reading 0

Biotech and Drug Stocks Down as Investors Trim Positions

Biopharmaceutical Stocks Sell-Off with Large Cap Drug Stocks High Flyers du jour-AEGR,INFI 10 Year Treasury Hits 2.13 Yield Caution-no new buys and all portfolio positions on hold Large cap drug stocks were the surprising loser today along with the healthcare sector in general. Investors have been driven to drug stocks seeking yield while benefiting from […]

Continue Reading 0

Bull Market Rolls On And Biotech Sector Hits New All Time Highs

BioBubble with No Trouble? Another green screen today with the usual suspects running in Rayno Biopharmaceuticals helped by the Bank of America Health Care Conference. Alexion (ALXN) up 2.86%, Biogen Idec (BIIB) up 3.19%, Gilead (GILD) up 3.27%, Pharmacyclics (PCYC) up 2.5%, and Seattle Genetics (SGEN) up 3.29% etc. etc. etc. In the bioETF world IBB hit […]

Continue Reading 0

Frothy Biotechs Hit By Amgen Earnings- Reiterate Caution

Biotech Sector Off All Time Highs This Week-IBB Down 2.5% The biotech melt-up that coincided with the surprising Vertex (VRTX) 60% move on April 19 has run its course and the IBB is now 7 pts off the all time high of $177.  Vertex was off 4.75% today. Daily trading volume was double the average. […]

Continue Reading 0

Is There No End to the Biotech Bull Market?

Biotechnology Sector Q2 2013- At All Time Highs  The BTK and ETFs such as the IBB and XBI hit all time highs on April 2. Of course the current  ramp cannot go on forever because money moves on, speculation ebbs and math intervenes.  We have been picking biotech stocks and forecasting this bull market since […]

Continue Reading 0

Biotech Stocks MOve Up Today for Impressive Q1 Performance: BIIB,IBB,GILD,REGN

Rayno Life Science Stocks Having A Nice Q1 Ending Run Well known Large Caps Dominate Rayno focus stocks that are running up 2% + today: AMGN, AMRI, ASTX, BIIB, GILD, QGEN, and REGN.  The Biopharma sector is outperforming Tools and Dx for Q1.   Tools and DX winners for the week are ALR, ILMN, and […]

Continue Reading 0